Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Elevance Health, Inc. (ELV) P/S ratio

As of 25 September 2026, Elevance Health, Inc. (ELV) trades at a P/S ratio of 0.4×. Over the past ten years it has ranged from 0.3× (March 2026) to 0.9× (February 2019); the current reading is higher than 12% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 0.4× (18.35%)
FY2024 0.5× (26.76%)
FY2023 0.7× (14.34%)
FY2022 0.8× (5.57%)
FY2021 0.8× 23.35%
FY2020 0.7× (10.76%)
FY2019 0.7× 0.61%
FY2018 0.7× 12.13%
FY2017 0.7× 47.94%
FY2016 0.4× (4.23%)

Quarterly

Period P/S ratio Change
Jun 2026 0.4× 29.96%
Mar 2026 0.3× (18.56%)
Dec 2025 0.4× 6.45%
Sep 2025 0.4× (19.98%)
42 more quarters

Against its own ten years

Low 0.3× High 0.9×
Ten-year median 0.6×
Current reading's percentile 12

P/S ratio against peers

Company P/S ratio
CNC Centene Corporation compare 0.2×
MOH Molina Healthcare, Inc compare 0.2×
CI Cigna Group compare 0.3×
CVS CVS Health Corporation compare 0.3×
HUM Humana Inc. compare 0.3×
ELV Elevance Health, Inc. 0.4×
OSCR Oscar Health, Inc. compare 0.6×
UNH UnitedHealth Group Incorporated compare 0.8×
CLOV Clover Health Investments, Corp. compare 1.0×
Healthcare Plans industry median 0.4×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on ELV